25 May 2013
Keywords: coartem, disp, debuts, africa, swiss, drug, major
Article | 23 February 2009
Swiss drug major Novartis and the non-profit Medicines for Malaria Venture have launched Coartem (artemether/ lumefantrine 20mg/120mg) Dispersible, the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.